Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740961 · ClinicalTrials.gov registry record
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 63
- Enrollment target
NCT00740961: Clinical Trial study, sponsored by Case Comprehensive Cancer Center.
NCT00740961 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00740961 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 63 participants
- Enrollment target
Study Summary
RATIONALE: Learning about changes over time in older patients' ability to function after receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying older patients with newly diagnosed breast cancer or colon cancer.
Interventions
- OTHER medical chart review
- OTHER survey administration
- OTHER study of socioeconomic and demographic variables
- DRUG systemic chemotherapy
- BEHAVIORAL compliance monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-09 |
Why NCT00740961 stopped before completion
NCT00740961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which medical chart review is the first listed.
NCT00740961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00740961 about?
NCT00740961 is a clinical study titled "Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer". RATIONALE: Learning about changes over time in older patients' ability to function after receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying older patients with newly ...
What is the current status of trial NCT00740961?
This trial is currently terminated. The enrollment target is 63 participants. The study started on 2008-03. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00740961?
The interventions under investigation include: medical chart review (OTHER), survey administration (OTHER), study of socioeconomic and demographic variables (OTHER), systemic chemotherapy (DRUG), compliance monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT00740961?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia